StockData
OMDANasdaqServices-Health ServicesFiscal year ends December 31

Omada Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$18.06+0.43 (+2.44%)

Close on Oct 19, 2026

Market cap
$1.15B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 5, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 6, 2026After market close$88.00M$0.08–
Q1 FY2026
Ended Mar 31, 2026
May 7, 2026After market close$78.00M––
Q4 FY2025
Ended Dec 31, 2025
Mar 5, 2026After market close$76.00M$0.08–
Q3 FY2025
Ended Sep 30, 2025
Nov 6, 2025After market close$68.00M$-0.06–
Q2 FY2025
Ended Jun 30, 2025
Aug 7, 2025After market close$61.00M––

Company guidance

Outlook given with results on Aug 6, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EBITDAnon-GAAPyear ending December 31, 2026$21.00M to $27.00MRaised
Revenueyear ending December 31, 2026$334.00M to $340.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Omada Health filed with the SEC